117 related articles for article (PubMed ID: 8653317)
1. Biological characteristics of inverted papilloma of the urinary bladder.
Urakami S; Igawa M; Shirakawa H; Shiina H; Ishibe T
Br J Urol; 1996 Jan; 77(1):55-60. PubMed ID: 8653317
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical analysis of proliferating cell nuclear antigen, p53 protein and nm23 protein, and nuclear DNA content in transitional cell carcinoma of the bladder.
Shiina H; Igawa M; Nagami H; Yagi H; Urakami S; Yoneda T; Shirakawa H; Ishibe T; Kawanishi M
Cancer; 1996 Oct; 78(8):1762-74. PubMed ID: 8859190
[TBL] [Abstract][Full Text] [Related]
3. Relationship of genetic instability with immunoreactivities for p53 protein and proliferating cell nuclear antigen in transitional cell carcinoma of the bladder.
Shiina H; Igawa M; Yagi H; Urakami S; Shirakawa H; Ishibe T
Eur Urol; 1996; 30(1):80-8. PubMed ID: 8854073
[TBL] [Abstract][Full Text] [Related]
4. [Proliferating character of inverted papilloma of the urinary bladder].
Tsujimura A; Takano Y; Oka T; Tei N; Satoh E; Gotoh T; Takaha M; Kurata A; Matsumiya K
Nihon Hinyokika Gakkai Zasshi; 1997 Jun; 88(6):618-23. PubMed ID: 9234619
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemistry of p53 protein in transitional-cell carcinoma of the bladder using an image analyzer.
Shiina H; Igawa M; Yagi H; Urakami S; Yoneda T; Shirakawa H; Ishibe T
Oncology; 1996; 53(3):233-40. PubMed ID: 8643227
[TBL] [Abstract][Full Text] [Related]
6. Significance of cyclin D1 overexpression in transitional cell carcinomas of the urinary bladder and its correlation with histopathologic features.
Lee CC; Yamamoto S; Morimura K; Wanibuchi H; Nishisaka N; Ikemoto S; Nakatani T; Wada S; Kishimoto T; Fukushima S
Cancer; 1997 Feb; 79(4):780-9. PubMed ID: 9024716
[TBL] [Abstract][Full Text] [Related]
7. Inverted urothelial papilloma: is ploidy, MIB-1 proliferative activity, or p53 protein accumulation predictive of urothelial carcinoma?
Cheville JC; Wu K; Sebo TJ; Cheng L; Riehle D; Lohse CM; Shane V
Cancer; 2000 Feb; 88(3):632-6. PubMed ID: 10649258
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of overexpression of p53 tumor suppressor protein in superficial and invasive transitional cell bladder cancer: comparison with DNA ploidy.
Nakopoulou L; Constantinides C; Papandropoulos J; Theodoropoulos G; Tzonou A; Giannopoulos A; Zervas A; Dimopoulos C
Urology; 1995 Sep; 46(3):334-40. PubMed ID: 7660508
[TBL] [Abstract][Full Text] [Related]
9. p53 and c-jun expression in urinary bladder transitional cell carcinoma: correlation with proliferating cell nuclear antigen (PCNA) histological grade and clinical stage.
Skopelitou A; Hadjiyannakis M; Dimopoulos D; Kamina S; Krikoni O; Alexopoulou V; Rigas C; Agnantis NJ
Eur Urol; 1997; 31(4):464-71. PubMed ID: 9187909
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical analysis of bcl-2 expression in transitional cell carcinoma of the bladder.
Shiina H; Igawa M; Urakami S; Honda S; Shirakawa H; Ishibe T
J Clin Pathol; 1996 May; 49(5):395-9. PubMed ID: 8707954
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical analysis of nm23 protein in transitional cell carcinoma of the bladder.
Shiina H; Igawa M; Urakami S; Shirakawa H; Ishibe T
Br J Urol; 1995 Dec; 76(6):708-13. PubMed ID: 8535713
[TBL] [Abstract][Full Text] [Related]
12. [Proliferative activity and p53 expression in transitional cell carcinoma of the urinary bladder].
Offner FA; Schäfer G; Hittmair A; Ofner D; Grünewald K; Weyrer K; Mattern D; Eberle J; Mikuz G; Feichtinger H
Verh Dtsch Ges Pathol; 1993; 77():241-6. PubMed ID: 7511289
[TBL] [Abstract][Full Text] [Related]
13. DNA content and proliferation activity in superficial transitional cell carcinoma of the bladder.
Pantazopoulos D; Ioakim-Liossi A; Karakitsos P; Aroni K; Kakoliris S; Kanavaros P; Kyrkou KA
Anticancer Res; 1997; 17(1B):781-6. PubMed ID: 9066620
[TBL] [Abstract][Full Text] [Related]
14. Expression of the human erythrocyte glucose transporter in transitional cell carcinoma of the bladder.
Chang S; Lee S; Lee C; Kim JI; Kim Y
Urology; 2000 Mar; 55(3):448-52. PubMed ID: 10699635
[TBL] [Abstract][Full Text] [Related]
15. Comparison of ureteropelvic transitional cell carcinoma with bladder transitional cell carcinoma using an image analyzer.
Shiina H; Igawa M; Urakami S; Shirakawa H; Ishibe T
Urol Int; 1996; 56(3):163-8. PubMed ID: 8860737
[TBL] [Abstract][Full Text] [Related]
16. Inverted papilloma of the urinary bladder: a case evaluated for malignant potential.
Urakami S; Igawa M; Shirakawa H; Shiina H; Ishibe T
Int Urol Nephrol; 1997; 29(2):181-7. PubMed ID: 9241545
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical analysis of p53 and proliferating cell nuclear antigen (PCNA) in bladder cancer: positive immunostaining and radiosensitivity.
Ogura K; Habuchi T; Yamada H; Ogawa O; Yoshida O
Int J Urol; 1995 Nov; 2(5):302-8. PubMed ID: 8749948
[TBL] [Abstract][Full Text] [Related]
18. Biomarker study of primary nonmetastatic versus metastatic invasive bladder cancer. National Cancer Institute Bladder Tumor Marker Network.
Lianes P; Charytonowicz E; Cordon-Cardo C; Fradet Y; Grossman HB; Hemstreet GP; Waldman FM; Chew K; Wheeless LL; Faraggi D
Clin Cancer Res; 1998 May; 4(5):1267-71. PubMed ID: 9607586
[TBL] [Abstract][Full Text] [Related]
19. p53 overexpression as a prognostic factor for advanced stage bladder cancer.
Kuczyk MA; Bokemeyer C; Serth J; Hervatin C; Oelke M; Höfner K; Tan HK; Jonas U
Eur J Cancer; 1995 Dec; 31A(13-14):2243-7. PubMed ID: 8652250
[TBL] [Abstract][Full Text] [Related]
20. Can p53 nuclear over-expression, Bcl-2 accumulation and PCNA status be of prognostic significance in high-risk superficial and invasive bladder tumours?
Plastiras D; Moutzouris G; Barbatis C; Presvelos V; Petrakos M; Theodorou C
Eur J Surg Oncol; 1999 Feb; 25(1):61-5. PubMed ID: 10188857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
